ELF4 is critical for induction of type i interferon and the host antiviral response

Nature Immunology

Volumn 14, Issue 12, 2013, Pages 1237-1246

  You, Fuping ^a   Wang, Penghua ^a   Yang, Long ^a   Yang, Guang ^a,d   Zhao, Yang O ^a,b   Qian, Feng ^a   Walker, Wendy ^a,b   Sutton, Richard ^a   Montgomery, Ruth ^a   Lin, Rongtuan ^c   Iwasaki, Akiko ^a,b   Fikrig, Erol ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c MCGILL UNIVERSITY   (Canada)

^d MEDICAL COLLEGE OF JINAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON; INTERFERON REGULATORY FACTOR 3; INTERFERON REGULATORY FACTOR 7; KRUPPEL LIKE FACTOR 4; MYELOID DIFFERENTIATION FACTOR 88; STING PROTEIN; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ELF4; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; INFECTION SENSITIVITY; INNATE IMMUNITY; INTERFERON INDUCTION; INTERFERON PRODUCTION; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION; VIRUS ENCEPHALITIS; WEST NILE FLAVIVIRUS; WEST NILE VIRUS ENCEPHALITIS;

ANIMALS; CELL LINE; CELLS, CULTURED; DNA-BINDING PROTEINS; HEK293 CELLS; HELA CELLS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNOBLOTTING; INTERFERON REGULATORY FACTOR-3; INTERFERON REGULATORY FACTOR-7; INTERFERON-BETA; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROSCOPY, CONFOCAL; PROTEIN BINDING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SURVIVAL ANALYSIS; TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION; WEST NILE FEVER; WEST NILE VIRUS;

EID: 84887996142     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.2756     Document Type: Article

References (49)

1. Takeuchi, O. & Akira, S. Innate immunity to virus infection. Immunol. Rev. 227, 75-86 (2009).
2. Liew, F.Y., Xu, D., Brint, E.K. & O'Neill, L.A. Negative regulation of toll-like receptor-mediated immune responses. Nat. Rev. Immunol. 5, 446-458 (2005). (Pubitemid 40835033)
3. Kawai, T. et al. IPS-1, an adaptor triggering RIG-I-and Mda5-mediated type I interferon induction. Nat. Immunol. 6, 981-988 (2005). (Pubitemid 41486182)
4. Meylan, E. et al. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437, 1167-1172 (2005). (Pubitemid 41509355)
5. Seth, R.B., Sun, L., Ea, C.K. & Chen, Z.J. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-B and IRF 3. Cell 122, 669-682 (2005). (Pubitemid 41242633)
6. Xu, L.G. et al. VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol. Cell 19, 727-740 (2005).
7. Barber, G.N. Cytoplasmic DNA innate immune pathways. Immunol. Rev. 243, 99-108 (2011).
8. Chiu, Y.H., Macmillan, J.B. & Chen, Z.J. RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway. Cell 138, 576-591 (2009).
9. Unterholzner, L. et al. IFI16 is an innate immune sensor for intracellular DNA. Nat. Immunol. 11, 997-1004 (2010).
10. Parvatiyar, K. et al. The helicase DDX41 recognizes the bacterial secondary messengers cyclic di-GMP and cyclic di-AMP to activate a type I interferon immune response. Nat. Immunol. 13, 1155-1161 (2012).
11. Sun, L., Wu, J., Du, F., Chen, X. & Chen, Z.J. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 339, 786-791 (2013).
12. Ishikawa, H. & Barber, G.N. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 455, 674-678 (2008).
13. Sun, W. et al. ERIS, an endoplasmic reticulum IFN stimulator, activates innate immune signaling through dimerization. Proc. Natl. Acad. Sci. USA 106, 8653-8658 (2009).
14. Zhong, B. et al. The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor activation. Immunity 29, 538-550 (2008).
15. Chen, H. et al. Activation of STAT6 by STING is critical for antiviral innate immunity. Cell 147, 436-446 (2011).
16. Daffis, S., Suthar, M.S., Szretter, K.J., Gale, M. Jr. & Diamond, M.S. Induction of IFN-beta and the innate antiviral response in myeloid cells occurs through an IPS-1-dependent signal that does not require IRF-3 and IRF-7. PLoS Pathog. 5, e1000607 (2009).
17. Yamada, T., Park, C.S., Mamonkin, M. & Lacorazza, H.D. Transcription factor ELF4 controls the proliferation and homing of CD8+ T cells via the Kruppel-like factors KLF4 and KLF2. Nat. Immunol. 10, 618-626 (2009).
18. Sashida, G. et al. ELF4/MEF activates MDM2 expression and blocks oncogene-induced p16 activation to promote transformation. Mol. Cell Biol. 29, 3687-3699 (2009).
19. Meadows, S.M., Myers, C.T. & Krieg, P.A. Regulation of endothelial cell development by ETS transcription factors. Semin. Cell Dev. Biol. 22, 976-984 (2011).
20. Sivina, M. et al. The transcription factor E74-like factor controls quiescence of endothelial cells and their resistance to myeloablative treatments in bone marrow. Arterioscler. Thromb. Vasc. Biol. 31, 1185-1191 (2011).
21. Yao, J.J. et al. Tumor promoting properties of the ETS protein MEF in ovarian cancer. Oncogene 26, 4032-4037 (2007). (Pubitemid 46884297)
22. Mao, S., Frank, R.C., Zhang, J., Miyazaki, Y. & Nimer, S.D. Functional and physical interactions between AML1 proteins and an ETS protein, MEF: implications for the pathogenesis of t(8;21)-positive leukemias. Mol. Cell Biol. 19, 3635-3644 (1999). (Pubitemid 29193823)
23. Gobin, S.J., Biesta, P. & Van den Elsen, P.J. Regulation of human beta 2-microglobulin transactivation in hematopoietic cells. Blood 101, 3058-3064 (2003). (Pubitemid 36857996)
24. Sauer, J.D. et al. The N-ethyl-N-nitrosourea-induced Goldenticket mouse mutant reveals an essential function of Sting in the in vivo interferon response to Listeria monocytogenes and cyclic dinucleotides. Infect. Immun. 79, 688-694 (2011).
25. You, F. et al. PCBP2 mediates degradation of the adaptor MAVS via the HECT ubiquitin ligase AIP4. Nat. Immunol. 10, 1300-1308 (2009).
26. Suico, M.A. et al. Functional dissection of the ETS transcription factor MEF. Biochim. Biophys. Acta 1577, 113-120 (2002). (Pubitemid 34876610)
27. Suthar, M.S. et al. IPS-1 is essential for the control of West Nile virus infection and immunity. PLoS Pathog. 6, e1000757 (2010).
28. Wang, T. et al. Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat. Med. 10, 1366-1373 (2004). (Pubitemid 40022719)
29. Lacorazza, H.D. et al. The ETS protein MEF plays a critical role in perforin gene expression and the development of natural killer and NK-T cells. Immunity 17, 437-449 (2002). (Pubitemid 35223533)
30. Diamond, M.S., Shrestha, B., Mehlhop, E., Sitati, E. & Engle, M. Innate and adaptive immune responses determine protection against disseminated infection by West Nile encephalitis virus. Viral Immunol. 16, 259-278 (2003). (Pubitemid 37229540)
31. Vargin, V.V. & Semenov, B.F. Changes of natural killer cell activity in different mouse lines by acute and asymptomatic flavivirus infections. Acta Virol. 30, 303-308 (1986). (Pubitemid 16048541)
32. Shrestha, B. & Diamond, M.S. Role of CD8+ T cells in control of West Nile virus infection. J. Virol. 78, 8312-8321 (2004). (Pubitemid 38944315)
33. Tough, D.F. Modulation of T-cell function by type I interferon. Immunol. Cell Biol. 90, 492-497 (2012).
34. Yokoyama, M. et al. Inducible histamine protects mice from P. acnes-primed and LPS-induced hepatitis through H2-receptor stimulation. Gastroenterology 127, 892-902 (2004). (Pubitemid 39208421)
35. Miyahira, A.K., Shahangian, A., Hwang, S., Sun, R. & Cheng, G. TANK-binding kinase-1 plays an important role during in vitro and in vivo type I IFN responses to DNA virus infections. J. Immunol. 182, 2248-2257 (2009).
36. Wei, G.H. et al. Genome-wide analysis of ETS-family DNA-binding in vitro and in vivo. EMBO J. 29, 2147-2160 (2010).
37. Nolan, G.P. NF-AT-AP-1 and Rel-bZIP: hybrid vigor and binding under the influence. Cell 77, 795-798 (1994).
38. Bonnefoy, E., Bandu, M.T. & Doly, J. Specific binding of high-mobility-group I (HMGI) protein and histone H1 to the upstream AT-rich region of the murine beta interferon promoter: HMGI protein acts as a potential antirepressor of the promoter. Mol. Cell Biol. 19, 2803-2816 (1999). (Pubitemid 29144524)
39. Collett, G.P. & Campbell, F.C. Overexpression of p65/RelA potentiates curcumin-induced apoptosis in HCT116 human colon cancer cells. Carcinogenesis 27, 1285-1291 (2006). (Pubitemid 43985444)
40. Sato, M. et al. Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity 13, 539-548 (2000).
41. Lazear, H.M. et al. IRF-3, IRF-5, and IRF-7 coordinately regulate the type I IFN response in myeloid dendritic cells downstream of MAVS signaling. PLoS Pathog. 9, e1003118 (2013).
42. Verger, A. & Duterque-Coquillaud, M. When Ets transcription factors meet their partners. BioEssays 24, 362-370 (2002).
43. Tussiwand, R. et al. Compensatory dendritic cell development mediated by BATF-IRF interactions. Nature 490, 502-507 (2012).
44. Glasmacher, E. et al. A genomic regulatory element that directs assembly and function of immune-specific AP-1-IRF complexes. Science 338, 975-980 (2012).
45. Papachristou, D.J., Batistatou, A., Sykiotis, G.P., Varakis, I. & Papavassiliou, A.G. Activation of the JNK-AP-1 signal transduction pathway is associated with pathogenesis and progression of human osteosarcomas. Bone 32, 364-371 (2003). (Pubitemid 36407536)
46. Panne, D., Maniatis, T. & Harrison, S.C. Crystal structure of ATF-2/c-Jun and IRF-3 bound to the interferon-beta enhancer. EMBO J. 23, 4384-4393 (2004). (Pubitemid 39601963)
47. Kong, K.F. et al. Dysregulation of TLR3 impairs the innate immune response to West Nile virus in the elderly. J. Virol. 82, 7613-7623 (2008).
48. Wang, P. et al. Caspase-12 controls West Nile virus infection via the viral RNA receptor RIG-I. Nat. Immunol. 11, 912-919 (2010).
49. Samuel, M.A. et al. PKR and RNase L contribute to protection against lethal West Nile virus infection by controlling early viral spread in the periphery and replication in neurons. J. Virol. 80, 7009-7019 (2006). (Pubitemid 44025199)